The Relevant disclosure is attached

Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector – 41, Gurgaon, Haryana – 122 001 (India) Tel 0124 492 1033 Fax 0124 492 1041 Emergency 105010 Email: secretarial@fortishealthcare.com Website : www.fortishealthcare.com August 06, 2026 FHL/SEC/2026-27 The National Stock Exchange of India Ltd. BSE Limited Scrip Symbol: FORTIS Scrip Code: 532843 Sub: Outcome of the Board Meeting under Regulation 30, 33 and 52 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Dear Madam/Sir, We hereby inform that the Board of Directors of the Company at its Meeting held today i.e. Thursday, August 06, 2026 have, inter-alia, considered and approved the following matters: Financial Results In terms of Regulations 30, 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') as amended, approved the Un-audited (Standalone and Consolidated) Financial Results of the Company for the quarter ended June 30, 2026 along with Limited Review Report given by M/s. B S R & Co. LLP, the Statutory Auditors of the Company. Accordingly, please find enclosed herewith Un-audited (Standalone and Consolidated) Financial Results of the Company along with Limited Review Report thereon given by the Statutory Auditors of the Company for the Quarter ended on June 30, 2026. Further, Certificate with respect to the compliance of Financial Covenants, in accordance with the applicable regulations or circulars, issued by the Statutory Auditors is also enclosed along with the financial results. Appointment of Tax Auditors Appointment of M/s. B S R & Co. LLP, Chartered Accountants (Registration No. 101248W/W-100022), as Tax Auditors of the Company for Financial Year 2025-26. The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, as amended from time to time is enclosed as Annexure-I The Board Meeting commenced at 12:00 Noon IST and concluded at 6:45 PM IST. FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel :0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933 This is for your information and records. Thanking you, Yours Sincerely, For Fortis Healthcare Limited Satyendra Chauhan Company Secretary & Compliance Officer M. No. - A14783 Encl : As stated above FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel :0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933 Annexure I Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master circular dated January 30, 2026 Sr. Particulars Description 1 Reason for change viz. appointment, re Re-Appointment of M/s. B S R & Co. LLP, Chartered appointment, resignation, removal, death Accountants (Registration No. 101248W/W-100022) as Tax or otherwise; Auditors of the Company 2 Date of appointment/re- M/s. B S R & Co. LLP, Chartered Accountants are appointed appointment/cessation (as applicable) & as the Tax Auditors of the Company effective from August term of appointment/re appointment 06, 2026 for Financial Year 2025-26 3 Brief profile (in case of appointment). B S R & Co. was constituted on 27 March 1990 as a partnership firm and was thereafter converted into limited liability partnership i.e. B S R & Co. LLP, on 14 October 2013. The registration no. of the firm is 101248W/W-100022. The registered office of the firm is at 14th Floor, Central B Wing and North C Wing, Nesco IT Park 4, Nesco Centre, Western Express Highway, Goregaon (East), Mumbai- 400063. B S R & Co. LLP is a member entity of B S R & Affiliates, a network registered with the Institute of Chartered Accountants of India. The firm has over 4000 staff and 170+ Partners and has offices across 14 locations. The firm audits various companies listed on stock exchanges in India including companies in the Healthcare sector” 4 Disclosure of relationships between Not Applicable. directors (in case of appointment of a director). FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel :0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933 B S R & Co. LLP Building No. 10, 12th Floor, Tower-C DLF Cyber City, Phase - II India Gurugram - 122 002, Chartered Accountants Tel: +91 124 719 1000 Fax. +91 124 235 8613 limited Review Report on unaudited standalone financial results of Fortis Healthcare Limited for the 2026 quarter ended 30 June pursuant to Regulation 33 and Regulation 52(4) read with Regulation 63 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Fortis Healthcare Limited 1. We have reviewed the accompanying Statement of unaudited standalone financial results of Fortis Healthcare Limited (hereinafter referred to as "the Company") for the quarter ended 30 June 2026 ("the Statement"). 2. This Statement, which is the responsibility of the Company's management and approved by its Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 and Regulation 52(4) read with Regulation 63 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations"). Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Attention is drawn to the fact that the figures for the three months ended 31 March 2026 as reported in the Statement are the balancing figures between audited figures in respect of the full previous financial year and the published year to date figures up to the third quarter of the previous financial year, The figures up to the end of the third quarter of previous financial year had only been reviewed and not subjected to audit. 5. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 and Regulation 52(4) read with Regulation 63 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. We draw attention to the following notes in the Statement: a. Note 8 and 9 of the Statement which deal with various matters including the ongoing investigation by Serious Fraud Investigation Office ("SFIO") on Fortis Healthcare Limited and its subsidiaries ("the Group") regarding alleged improper transactions and non-compliances with laws and regulations including Companies Act, 2013 (inclu [Showing first 8,000 characters — download PDF for full document]